<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Glycosyn on 生物经济</title><link>https://cn.bioecon.ru/companies/glycosyn/</link><description>Recent content in Glycosyn on 生物经济</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Sun, 05 Jul 2026 22:49:34 +0700</lastBuildDate><atom:link href="https://cn.bioecon.ru/companies/glycosyn/index.xml" rel="self" type="application/rss+xml"/><item><title>母乳低聚糖（HMO）</title><link>https://cn.bioecon.ru/technology/human-milk-oligosaccharides-hmos/</link><pubDate>Sun, 05 Jul 2026 00:00:00 +0000</pubDate><guid>https://cn.bioecon.ru/technology/human-milk-oligosaccharides-hmos/</guid><description>由工程化大肠杆菌或酵母生产的精密发酵母乳低聚糖——2&amp;rsquo;-岩藻糖基乳糖、LNnT及唾液酸化糖——为婴儿配方奶粉中的双歧杆菌提供营养并阻断病原体附着，如今正从婴儿营养领域扩展至成人肠道健康补充剂。</description></item></channel></rss>